INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

ORGOOrganogenesis Holdings Inc.

CIK 0001661181

EDGAR filingsOpen in network
Disclosed transactions60
Buys / sells2 / 0
Max Insider Score34
Connections16with evidence

ORGO · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Option exercise
M—
958 sh
Jan 10, 2025Apr 24, 2026
traded Jan 10, 2025
+469dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Quintero GilbertoDirector · Feb 20, 2026
  • ← Insider ofevidence
    Duraibabu PrathyushaDirector · Feb 20, 2026
  • ← Insider ofevidence
    Lustig GarrettDirector · Feb 20, 2026
  • ← Insider ofevidence
24
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Option exercise
M
$1,188
958 sh
Jan 10, 2025
Apr 24, 2026
traded Jan 10, 2025
+469d
SEC FORM 4

Evidence

34
DJ
Driscoll Michael JosephDirector
ORGOOrganogenesis Holdings Inc.
Open-market purchase
BUY$27K
10.0K sh
Mar 9, 2026Mar 11, 2026
traded Mar 9, 2026
+2dSEC FORM 4

Evidence

34
LS
Leibowitz Arthur SDirector
ORGOOrganogenesis Holdings Inc.
Open-market purchase
BUY$13K
5,000 sh
Mar 9, 2026Mar 11, 2026
traded Mar 9, 2026
+2dSEC FORM 4

Evidence

9
CR
Cavorsi RobertVice President, Strategy
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$2,247
700 sh
Mar 1, 2026Mar 3, 2026
traded Mar 1, 2026
+2dSEC FORM 4

Evidence

21
CR
Cavorsi RobertVice President, Strategy
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
93.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

13
CR
Cavorsi RobertVice President, Strategy
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
16.3K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
CR
Cavorsi RobertVice President, Strategy
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$21K
5,432 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
CR
Cavorsi RobertVice President, Strategy
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
53.5K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

17
FD
Francisco DavidChief Financial Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
195.3K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

13
FD
Francisco DavidChief Financial Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
43.6K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

17
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
234.4K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

13
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.3K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$45K
11.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
133.6K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

17
BP
Bilbo PatrickChief Operating Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
210.9K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

12
BP
Bilbo PatrickChief Operating Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$62K
16.2K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
BP
Bilbo PatrickChief Operating Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
120.3K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

17
GS
Gillheeney Gary S.Director, President and CEO
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
890.6K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
GS
Gillheeney Gary S.Director, President and CEO
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
187.0K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

15
GS
Gillheeney Gary S.Director, President and CEO
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$347K
90.4K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
GS
Gillheeney Gary S.Director, President and CEO
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
507.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

17
DJ
Driscoll Michael JosephDirector
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

17
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
40.6K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

13
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
11.2K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$14K
3,741 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

17
DP
Duraibabu PrathyushaDirector
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

12
FD
Francisco DavidChief Financial Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$56K
14.5K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
FD
Francisco DavidChief Financial Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
111.4K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
BP
Bilbo PatrickChief Operating Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.6K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

17
FL
Freedman LoriChief Admin. and Legal Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
203.1K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
FL
Freedman LoriChief Admin. and Legal Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
42.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

12
FL
Freedman LoriChief Admin. and Legal Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$55K
14.3K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
FL
Freedman LoriChief Admin. and Legal Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
115.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

21
LG
Lustig GarrettDirector
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

17
LS
Leibowitz Arthur SDirector
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
23.2K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

17
GL
Giacomin Jon LDirector
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

17
QG
Quintero GilbertoDirector
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

17
KI
Korfin Michele IleneDirector
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

15
FD
Francisco DavidChief Financial Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$50K
13.4K sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

19
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$36K
9,607 sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

15
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$15K
4,100 sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

15
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$13K
3,523 sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

15
CR
Cavorsi RobertVice President, Strategy
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$21K
5,549 sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

15
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$42K
11.1K sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

18
FD
Francisco DavidChief Financial Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$80K
21.4K sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

15
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$5,181
1,389 sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

21
GS
Gillheeney Gary S.Director, President and CEO
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$309K
82.8K sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

21
GS
Gillheeney Gary S.Director, President and CEO
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$319K
85.6K sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

18
FD
Francisco DavidChief Financial Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$51K
13.8K sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

15
FD
Francisco DavidChief Financial Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$15K
3,898 sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

15
BP
Bilbo PatrickChief Operating Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$19K
5,114 sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

18
BP
Bilbo PatrickChief Operating Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$106K
28.3K sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

18
BP
Bilbo PatrickChief Operating Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$58K
15.6K sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

18
BP
Bilbo PatrickChief Operating Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$57K
15.4K sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

15
CR
Cavorsi RobertVice President, Strategy
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$25K
6,667 sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

15
CR
Cavorsi RobertVice President, Strategy
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$20K
5,442 sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

15
FL
Freedman LoriChief Admin. and Legal Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$15K
4,043 sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

18
FL
Freedman LoriChief Admin. and Legal Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$91K
24.4K sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

Korfin Michele Ilene
Director · Feb 20, 2026
  • ← Insider ofevidence
    Giacomin Jon LDirector · Feb 20, 2026
  • ← Insider ofevidence
    Driscoll Michael JosephDirector · Feb 20, 2026
  • ← Insider ofevidence
    Leibowitz Arthur SDirector · Feb 20, 2026
  • ← Insider ofevidence
    Freedman LoriChief Admin. and Legal Officer · Feb 18, 2026
  • ← Insider ofevidence
    Grow BrianChief Commercial Officer · Feb 18, 2026
  • ← Insider ofevidence
    Montecalvo Antonio S.Vice President, Health Policy · Feb 18, 2026
  • ← Insider ofevidence
    Gillheeney Gary S.Director, President and CEO · Feb 18, 2026
  • ← Insider ofevidence
    Francisco DavidChief Financial Officer · Feb 18, 2026
  • ← Insider ofevidence
    Cavorsi RobertVice President, Strategy · Feb 18, 2026
  • ← Insider ofevidence
    Bilbo PatrickChief Operating Officer · Feb 18, 2026
  • ← Insider ofevidence
    Nussdorf Glenn HDirector, 10% Owner · Nov 26, 2025